Blog post | LabGenius' CTO, Leonard Wossnig, introduces the 5 'V's of drug discovery data in a recent blog post
Get to know LabGenius' CTO, Ex-Rahko co-founder & CEO and former VP of AI Odyssey Therapeutics, Dr Leonard Wossnig.
Q&A with Justin Grace, Senior Data Scientist @ LabGenius
Ex-Google CFO and LabGenius Investor, Patrick Pichette, shares his advice for scaling with efficiency
Q&A with Dr. Dan Foxler, Principal Scientist @ LabGenius
LabGenius tops up Series A to $25M
How to build a platform to design new protein therapeutics
How LabGenius is revolutionising drug discovery with machine learning
Data, drugs, and deep learning
AI-driven protein engineering, Silicon Scientists and startup investment
